Helena Port Selected Research

Metalloproteases (Metalloproteinases)

1/2024

Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helena Port Research Topics

Disease

3	Axial Spondyloarthritis 01/2024 - 01/2022
3	Ankylosing Spondylitis 01/2024 - 12/2022
2	Inflammation (Inflammations) 01/2024 - 01/2022
2	Rheumatoid Arthritis 12/2023 - 12/2022
2	Osteoarthritis 12/2023 - 12/2022
1	Pain (Aches) 05/2023
1	Joint Diseases (Joint Disease) 05/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023
1	Hidradenitis Suppurativa 01/2023
1	Pelvic Pain 01/2022
1	Back Pain (Backache) 01/2022

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2022
3	Matrix Metalloproteinases (MMPs)IBA 01/2024 - 01/2022
2	CollagenIBA 01/2024 - 01/2022
2	Adalimumab (Humira)FDA Link 01/2024 - 01/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2024
1	VimentinIBA 01/2024
1	Calcineurin InhibitorsIBA 01/2023
1	Collagen Type VIIBA 01/2023
1	Insulin (Novolin)FDA Link 12/2022
1	Collagen Type II (Type II Collagen)IBA 12/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	catch-relaxing peptide (Mytilus)IBA 01/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022

Therapy/Procedure

1	Therapeutics 01/2023